The Ocular Hypertension Treatment Study: design and baseline description of the participants.

Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol (2008) 3.25

The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data. Arch Ophthalmol (2009) 2.59

Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology (2012) 2.35

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology (2006) 2.28

Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol (2010) 2.14

African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes. Arch Ophthalmol (2010) 1.89

Pattern electroretinogram abnormality and glaucoma. Ophthalmology (2005) 1.82

Diurnal intraocular pressure patterns are not repeatable in the short term in healthy individuals. Ophthalmology (2010) 1.72

Comparison of automated analysis of Cirrus HD OCT spectral-domain optical coherence tomography with stereo photographs of the optic disc. Ophthalmology (2011) 1.71

The utility of the monocular trial: data from the ocular hypertension treatment study. Ophthalmology (2010) 1.61

Diagnostic tools for glaucoma detection and management. Surv Ophthalmol (2008) 1.58

Reproducibility of retinal nerve fiber layer thickness measurements using spectral domain optical coherence tomography. J Glaucoma (2011) 1.46

Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.44

Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc (2001) 1.42

Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology (2011) 1.23

Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage. Ophthalmology (2014) 1.18

Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study. Arch Ophthalmol (2010) 1.18

Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging. Br J Ophthalmol (2010) 1.13

Evaluation of a combined index of optic nerve structure and function for glaucoma diagnosis. BMC Ophthalmol (2011) 1.12

Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology (2009) 1.06

Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study. Ophthalmology (2010) 1.05

Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study. Am J Ophthalmol (2006) 1.05

Causes of visual impairment and common eye problems in Northwest American Indians and Alaska Natives. Am J Public Health (2005) 1.03

Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci (2012) 1.03

Diagnostic capability of spectral-domain optical coherence tomography for glaucoma. Am J Ophthalmol (2012) 1.02

Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts. Invest Ophthalmol Vis Sci (2013) 1.00

Copy number variations and primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2011) 0.99

Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Invest Ophthalmol Vis Sci (2013) 0.99

The rate of visual field change in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2012) 0.98

A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci. PLoS One (2013) 0.97

The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clin Ophthalmol (2009) 0.95

Progression of patterns (POP): a machine classifier algorithm to identify glaucoma progression in visual fields. Invest Ophthalmol Vis Sci (2012) 0.93

Pattern electroretinogram progression in glaucoma suspects. J Glaucoma (2013) 0.92

Symmetry between the right and left eyes of the normal retinal nerve fiber layer measured with optical coherence tomography (an AOS thesis). Trans Am Ophthalmol Soc (2008) 0.92

Head-down posture induces PERG alterations in early glaucoma. J Glaucoma (2013) 0.91

Progressive loss of retinal ganglion cell function is hindered with IOP-lowering treatment in early glaucoma. Invest Ophthalmol Vis Sci (2012) 0.91

Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study. Invest Ophthalmol Vis Sci (2013) 0.91

Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle Glaucoma. BMC Ophthalmol (2012) 0.91

Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology (2013) 0.90

The Connective Tissue Components of Optic Nerve Head Cupping in Monkey Experimental Glaucoma Part 1: Global Change. Invest Ophthalmol Vis Sci (2015) 0.90

Visual field improvement in the collaborative initial glaucoma treatment study. Am J Ophthalmol (2014) 0.90

Advanced imaging for glaucoma study: design, baseline characteristics, and inter-site comparison. Am J Ophthalmol (2014) 0.89

Peripapillary fundus perimetry in eyes with glaucoma. Br J Ophthalmol (2006) 0.89

Evaluation of relationship between retinal nerve fiber layer thickness progression and visual field progression in patients with glaucoma. Jpn J Ophthalmol (2013) 0.89

Quality of Life in Glaucoma: A Review of the Literature. Adv Ther (2016) 0.87

Assessment of SNPs associated with the human glucocorticoid receptor in primary open-angle glaucoma and steroid responders. Mol Vis (2010) 0.87

A new method for determining physician decision thresholds using empiric, uncertain recommendations. BMC Med Inform Decis Mak (2010) 0.87

Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma. Clin Ophthalmol (2015) 0.87

Diagnostic capability of peripapillary retinal thickness in glaucoma using 3D volume scans. Am J Ophthalmol (2014) 0.86

The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals. Ophthalmology (2008) 0.85

Refinement of pointwise linear regression criteria for determining glaucoma progression. Invest Ophthalmol Vis Sci (2013) 0.84

Adaptation of the steady-state PERG in early glaucoma. J Glaucoma (2014) 0.84

Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study. Ophthalmology (2013) 0.84

Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma. Jpn J Ophthalmol (2010) 0.83

Relationship Between Fuchs Endothelial Corneal Dystrophy Severity and Glaucoma and/or Ocular Hypertension. Arch Ophthalmol (2012) 0.83

The incidence of retinal vein occlusion in the ocular hypertension treatment study. Ophthalmology (2010) 0.83

[Conventional perimetry. Antiquated or indispensable for functional glaucoma diagnostics?]. Ophthalmologe (2012) 0.83

Glaucoma detection with matrix and standard achromatic perimetry. Br J Ophthalmol (2007) 0.81

Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management. Ophthalmol Ther (2016) 0.80

The PERG in diabetic glaucoma suspects with no evidence of retinopathy. J Glaucoma (2010) 0.80

Some dissociating factors in the analysis of structural and functional progressive damage in open-angle glaucoma. Br J Ophthalmol (2006) 0.80

Pattern electroretinogram optimized for glaucoma screening (PERGLA) and retinal nerve fiber thickness in suspected glaucoma and ocular hypertension. Doc Ophthalmol (2009) 0.80

Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes Arch Clin Exp Ophthalmol (2009) 0.80

[Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?]. Ophthalmologe (2013) 0.79

Utility of digital stereo images for optic disc evaluation. Invest Ophthalmol Vis Sci (2010) 0.79

Analysis of neuroretinal rim distribution and vascular pattern in eyes with presumed large physiological cupping: a comparative study. BMC Ophthalmol (2014) 0.79

Descemet stripping with automated endothelial keratoplasty: A comparative study of outcome in patients with preexisting glaucoma. Saudi J Ophthalmol (2013) 0.78

Applanation tonometry: a comparison of the Perkins handheld and Goldmann slit lamp-mounted methods. Clin Ophthalmol (2014) 0.78

Boosting the Power of the Sequence Kernel Association Test by Properly Estimating Its Null Distribution. Am J Hum Genet (2016) 0.78

Frequency Doubling Technology vs Standard Automated Perimetry in Ocular Hypertensive Patients. Open Ophthalmol J (2009) 0.77

Longitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment. Ophthalmology (2014) 0.77

Correlation of localized glaucomatous visual field defects and spectral domain optical coherence tomography retinal nerve fiber layer thinning using a modified structure-function map for OCT. Eye (Lond) (2015) 0.77

Diagnostic Capability of Peripapillary 3D Retinal Nerve Fiber Layer Volume for Glaucoma Using Optical Coherence Tomography Volume Scans. Am J Ophthalmol (2017) 0.76

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) study: findings at 3 months. Clin Ophthalmol (2013) 0.76

Rate of progression of total, upper, and lower visual field defects in patients with open-angle glaucoma and high myopia. Jpn J Ophthalmol (2016) 0.76

[Results of the "Ocular hypertension treatment study"]. Ophthalmologe (2005) 0.76

Optic nerve head morphology and visual field function in patients with AIDS and without infectious retinitis. Ocul Immunol Inflamm (2012) 0.76

Progression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies. Trans Am Ophthalmol Soc (2002) 0.76

The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland. J Ophthalmol (2015) 0.76

The effect of medical therapy on IOP control in Ghana. Ghana Med J (2014) 0.75

Head-down Posture in Glaucoma Suspects Induces Changes in IOP, Systemic Pressure, and PERG That Predict Future Loss of Optic Nerve Tissue. J Glaucoma (2017) 0.75

Clinical relevance of the glucocorticoid receptor gene polymorphisms in glucocorticoid-induced ocular hypertension and primary open angle glaucoma. Int J Ophthalmol (2015) 0.75

Effect of Refractive Correction Error on Retinal Nerve Fiber Layer Thickness: A Spectralis Optical Coherence Tomography Study. Med Sci Monit (2016) 0.75

A few remarks about glaucoma. Br J Ophthalmol (2002) 0.75

African Descent and Glaucoma Evaluation Study (ADAGES): Racial Differences in Optic Disc Hemorrhage and Beta-Zone Parapapillary Atrophy. Ophthalmology (2016) 0.75

Reproducibility of visual field end point criteria for standard automated perimetry, full-threshold, and Swedish interactive thresholding algorithm strategies: diagnostic innovations in glaucoma study. Am J Ophthalmol (2007) 0.75

Stereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular Hypertension. Invest Ophthalmol Vis Sci (2015) 0.75

Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study. Ophthalmology (2016) 0.75

Large-scale survey of unselected automated visual fields in a major reading center: patterns and data analysis. Scientifica (Cairo) (2012) 0.75

False negative results in glaucoma detection with Heidelberg Retina Tomograph II. Clin Ophthalmol (2008) 0.75

Glaucoma studies from 1996 to 1999 in peer-reviewed journals. Graefes Arch Clin Exp Ophthalmol (2005) 0.75

Evaluation of lamina cribrosa thickness and depth in ocular hypertension. Jpn J Ophthalmol (2015) 0.75

A gene-based test of association through an orthogonal decomposition of genotype scores. Hum Genet (2017) 0.75

Compliance with topical pilocarpine treatment. Am J Ophthalmol (1986) 2.48

Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology (2001) 2.35

Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol (2001) 2.30

Compliance with ocular therapy. Surv Ophthalmol (1980) 1.99

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol (1986) 1.64

Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol (2000) 1.62

Compliance with topical timolol treatment. Am J Ophthalmol (1987) 1.54

Multivariate analysis of the risk of glaucomatous visual field loss. Arch Ophthalmol (1979) 1.44

Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol (1978) 1.40

Primary valve malfunction of the Krupin eye valve with disk. J Glaucoma (1997) 1.39

Part I. Patient administration of eyedrops: interview. Ann Ophthalmol (1982) 1.34

Prognostic significance of optic disk cupping in ocular hypertensive patients. Am J Ophthalmol (1980) 1.29

Prognostic factors in glaucomatous visual field loss. Arch Ophthalmol (1976) 1.15

Timolol maleate: efficacy and safety. Arch Ophthalmol (1979) 1.13

Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol (1981) 1.12

Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma (1997) 1.12

The effect of a generic drug law on the retail cost of antiglaucoma medications. Am J Ophthalmol (1981) 1.11

Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol (1993) 1.09

Patient administration of eyedrops: observation. Part II. Ann Ophthalmol (1982) 1.09

Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension. Ophthalmology (1996) 1.06

Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. Am J Ophthalmol (2000) 1.06

Glaucomatocyclitic crisis and primary open-angle glaucoma. Am J Ophthalmol (1973) 1.03

Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmology (1984) 1.02

Trabeculectomy with releasable sutures. Arch Ophthalmol (1994) 1.01

Parapapillary chorioretinal atrophy in patients with ocular hypertension. I. An evaluation as a predictive factor for the development of glaucomatous damage. Arch Ophthalmol (1997) 1.00

Hormonal regulation of intraocular pressure. Surv Ophthalmol (1978) 1.00

A miniature compliance monitor for eyedrop medication. Arch Ophthalmol (1984) 0.99

Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol (1981) 0.98

Central corneal endothelial cell density and central corneal thickness in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol (1982) 0.97

Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. Am J Ophthalmol (1988) 0.96

Histocompatibility antigens and primary open-angle glaucoma. A reassessment. Arch Ophthalmol (1978) 0.96

A dose-response study of the effect of levobunolol on ocular hypertension. Am J Ophthalmol (1983) 0.96

Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects. Doc Ophthalmol (1990) 0.96

Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Invest Ophthalmol Vis Sci (1979) 0.94

Efficacy and patient acceptance of pilocarpine gel. Am J Ophthalmol (1979) 0.93

Timolol and epinephrine: a clinical study of ocular interactions. Arch Ophthalmol (1980) 0.91

Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps. Ophthalmic Surg Lasers (1997) 0.89

Compliance and prognosis in glaucoma. Arch Ophthalmol (1985) 0.89

Parapapillary chorioretinal atrophy in patients with ocular hypertension. II. An evaluation of progressive changes. Arch Ophthalmol (1997) 0.88

Quantitative visual field and optic disc correlates early in glaucoma. Arch Ophthalmol (1978) 0.88

Long-term epinephrine therapy of ocular hypertension. Arch Ophthalmol (1976) 0.88

Positive FTA-ABS tests in subjects with corticosteroid-induced uveitis. Am J Ophthalmol (1976) 0.87

Anterior lamellar sclerectomy for nanophthalmos. J Glaucoma (1992) 0.87

Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics. J Glaucoma (1998) 0.87

Prostaglandin synthesis, inhibition, and intraocular pressure. Invest Ophthalmol (1973) 0.87

Intraocular pressure and glaucoma in the Zuni indians. Arch Ophthalmol (1978) 0.86

Flurbiprofen and intraocular pressure. Ann Ophthalmol (1981) 0.86

Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study. Arch Ophthalmol (1979) 0.86

Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses. Ophthalmic Surg Lasers (1997) 0.86

Prostaglandin E 1 and aqueous humor dynamics. Invest Ophthalmol (1972) 0.85

Increased ocular and systemic responsiveness to epinephrine in primary open-angle glaucoma. Arch Ophthalmol (1977) 0.85

Low-dose methazolamide and intraocular pressure. Am J Ophthalmol (1977) 0.84

Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development. Ophthalmology (2000) 0.82

The pigment dispersion syndrome. Am J Ophthalmol (1977) 0.81

Retail cost of antiglaucoma drugs in two cities. Am J Ophthalmol (1978) 0.81

Trabeculectomy with releasable sutures. Trans Am Ophthalmol Soc (1993) 0.80

Retinitis pigmentosa associated with nevus flammeus and unilateral glaucoma. Ann Ophthalmol (1977) 0.80

MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology (1991) 0.79

Transscleral neodymium: YAG laser cyclocoagulation for uncontrolled glaucoma. Ophthalmic Surg (1990) 0.79

The effect of topical clonidine on intraocular pressure. Arch Ophthalmol (1981) 0.79

Histopathologic findings after Nd:YAG transscleral cyclophotocoagulation. Am J Ophthalmol (1988) 0.79

Cataract extraction in an eye with filtering bleb. Ophthalmology (1982) 0.79

Increased intraocular pressure after cataract surgery. Semin Ophthalmol (1994) 0.79

Plasma cortisol suppression test used to predict the development of primary open-angle glaucoma. Am J Ophthalmol (1976) 0.79

Pilocarpine ocular inserts. Invest Ophthalmol (1976) 0.78

Acute intraocular pressure response to argon laser iridotomy. Ophthalmology (1985) 0.78

Timolol plus maximum tolerated antiglaucoma therapy: a one-year followup study. Surv Ophthalmol (1979) 0.77

Repeat argon laser trabeculoplasty. Am J Ophthalmol (1987) 0.77

Timolol plus maximum-tolerated antiglaucoma therapy. Arch Ophthalmol (1979) 0.77

Chronic topical corticosteroid use simulating congenital glaucoma. J Pediatr (1972) 0.77

MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action. Arch Ophthalmol (1990) 0.77

Timolol and epinephrine: long-term evaluation of concurrent administration. Arch Ophthalmol (1982) 0.77

Intraocular pressure and visual field progression in open-angle glaucoma. Am J Ophthalmol (2000) 0.77

Normal-pressure glaucoma. Am J Ophthalmol (1998) 0.77

Traumatic rupture of healed cataract wounds. Am J Ophthalmol (1976) 0.76

Indomethacin blocks arachidonic acid-induced elevation of intraocular pressure. Prostaglandins (1973) 0.76

Wrong drug dispensed. JAMA (1977) 0.76

The ocular anti-inflammatory action of imidazole. Invest Ophthalmol Vis Sci (1977) 0.76

Efficacy of combining timolol with other antiglaucoma medications. Surv Ophthalmol (1983) 0.76

Systemic aspirin and indomethacin do not prevent the response of the monkey eye to trauma. Invest Ophthalmol (1975) 0.76

The effect of d-isoproterenol on intraocular pressure of the rabbit, monkey, and man. Invest Ophthalmol (1976) 0.76

Molteno implants in children. J Glaucoma (1992) 0.76

Timolol and acetazolamide. A study of concurrent administration. Arch Ophthalmol (1982) 0.76

Dipivefrin: current concepts. Aust J Ophthalmol (1980) 0.75

Madarosis in chronic epinephrine therapy. Arch Ophthalmol (1972) 0.75

Prostaglandin and thromboxane synthesis by microsomes of inflamed rabbit ciliary body--iris. Invest Ophthalmol Vis Sci (1981) 0.75

The association of HLA-B7 and HLA-B12 antigens with cup/disk ratio, family history of glaucoma, and intraocular pressure. Am J Ophthalmol (1977) 0.75

Corticosteroid responsiveness and herpes simplex. Lancet (1976) 0.75

Ocular abnormalities in a patient with Rothmund-Thomson syndrome. J Pediatr Ophthalmol Strabismus (1995) 0.75

Timolol and acetazolamide. Ann Ophthalmol (1983) 0.75

Combined procedures for cataract and glaucoma. Int Ophthalmol Clin (1984) 0.75

Acetazolamide and urolithiasis. Ophthalmology (1981) 0.75

Iridectomy in rubeosis iridis. Ophthalmic Surg (1976) 0.75

Corticosteroid-induced iridocyclitis in a family. Am J Ophthalmol (1982) 0.75

Total third nerve paralysis. Recovery in a case of meningococcic meningitis. Arch Ophthalmol (1972) 0.75

When to treat ocular hypertension. Ann Ophthalmol (1983) 0.75

Amorphous coating in open-angle glaucoma. Am J Ophthalmol (1981) 0.75

Experimental iridectomy with bipolar microcautery. Am J Ophthalmol (1976) 0.75

Russell-Silver dwarfism. Ann Ophthalmol (1976) 0.75

When to treat ocular hypertension. Surv Ophthalmol (1983) 0.75